Anthropic's $400M Acquisition of Coefficient Bio: A Strategic Pivot to AI-Driven Biotechnology and Vertical Integration
Anthropic has officially entered the high-stakes world of biotechnology with the $400 million acquisition of Coefficient Bio. This move signals a shift from general-purpose LLMs to specialized vertical integration, aiming to revolutionize drug discovery while navigating complex regulatory and safety landscapes.